| 12427187 |
Glucose-responsive insulin conjugates |
Danqing Feng, Songnian Lin, Dmitri Pissarnitski, Brenda Pipik, Yuping Zhu |
2025-09-30 |
|
| 11820805 |
Conjugate based systems for controlled insulin delivery |
Pei Huo, Ahmet Kekec, Danqing Feng, Yuping Zhu, Dmitri Pissarnitski +2 more |
2023-11-21 |
$219,447,000 |
| 11058775 |
Insulin dimer-incretin conjugates |
Anandan Palani, Zhiqiang Yang, Songnian Lin, Pei Huo, Ravi Nargund |
2021-07-13 |
$96,899,000 |
| 11041009 |
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes |
Danqing Feng, Pei Huo, Ahmet Kekec, Songnian Lin, Christopher Moyes +4 more |
2021-06-22 |
$110,392,000 |
| 10800827 |
Insulin receptor partial agonists |
Songnian Lin, Pei Huo, Dmitri Pissarnitski, Danqing Feng, Ravi Nargund +6 more |
2020-10-13 |
$388,195,000 |
| 10689430 |
Insulin receptor partial agonists |
Songnian Lin, Pei Huo, Dmitri Pissarnitski, Danqing Feng, Ravi Nargund +4 more |
2020-06-23 |
$115,870,000 |
| 10183981 |
Insulin receptor partial agonists |
Songnian Lin, Pei Huo, Dmitri Pissarnitski, Danqing Feng, Ravi Nargund +6 more |
2019-01-22 |
|
| 10017556 |
Insulin receptor partial agonists |
Songnian Lin, Pei Huo, Dmitri Pissarnitski, Danqing Feng, Ravi Nargund +6 more |
2018-07-10 |
$105,506,000 |
| 9889205 |
Glucose-responsive insulin conjugates |
Songnian Lin, Pei Huo |
2018-02-13 |
$69,479,000 |
| 9427475 |
Glucose-responsive insulin conjugates |
Songnian Lin, Pei Huo |
2016-08-30 |
$102,397,000 |
| 9272987 |
Diazeniumdiolate cyclohexyl derivatives |
Amjad Ali, Michael Man-Chu Lo |
2016-03-01 |
$86,173,000 |
| 9265774 |
Methods, compounds and pharmaceutical compositions for treating anxiety and mood disorders |
Eric A. Stone, David Quartermain, Yasmeen Sarfraz |
2016-02-23 |
|
| 9108920 |
Diazeniumdiolate heterocyclic derivatives |
Amjad Ali, Michael Man-Chu Lo, Robert K. Baker, Zhiqiang Guo, Brent Whitehead +5 more |
2015-08-18 |
$66,173,000 |
| 8648058 |
Diazeniumdiolate cyclopentyl derivatives |
Amjad Ali, Michael Man-Chu Lo, Edward Metzger |
2014-02-11 |
$103,107,000 |
| 8623846 |
Diazeniumdiolate cyclohexyl derivatives |
Amjad Ali, Pei Huo, Ravi Nargund |
2014-01-07 |
$63,301,000 |
| 8377911 |
Diuretics |
Amjad Ali, Michael Man-Chu Lo |
2013-02-19 |
$53,314,000 |
| 8361994 |
Primary amine diazeniumdiolate heterocyclic derivatives |
Amjad Ali, Michael Man-Chu Lo, Zhiqiang Guo, Brent Whitehead, Timothy J. Henderson +1 more |
2013-01-29 |
$43,785,000 |
| 8354394 |
Diuretics |
Amjad Ali, Christopher Franklin, Ravi Nargund, Michael Man-Chu Lo, Pei Huo |
2013-01-15 |
$88,184,000 |
| 8119806 |
Cicletanine derivatives |
Amjad Ali, Iyassu Sebhat, Christopher Franklin, Kathleen M. Rupprecht, Robert K. Baker +7 more |
2012-02-21 |
$50,558,000 |
| 7999107 |
Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
John S. Debenham, Jeffrey J. Hale, Pei Huo, Christina B. Madsen-Duggan, Thomas F. Walsh |
2011-08-16 |
$53,618,000 |
| 7659294 |
2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists |
Jeffrey J. Hale |
2010-02-09 |
$106,165,000 |
| 7605171 |
(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists |
Vincent J. Colandrea, George A. Doherty, Jeffrey J. Hale, Pei Huo, Irene E. Legiec +2 more |
2009-10-20 |
$116,613,000 |
| 7582654 |
Heterocyclo inhibitors of potassium channel function |
John Lloyd, Yoon Jeon, Heather Finlay, Michael Gross, Serge Beaudoin |
2009-09-01 |
|
| 7541362 |
Heterocyclic dihydropyrimidine compounds |
Karnail Atwal, Wayne Vaccaro, John Lloyd, Heather Finlay, Rao Bhandaru |
2009-06-02 |
$43,049,000 |
| 7202253 |
Cycloalkyl inhibitors of potassium channel function |
John Lloyd, Yoon Jeon, Heather Finlay, Michael Gross, Serge Beaudoin |
2007-04-10 |
|
